17 Einträge gefunden

1. BLEACH&STAIN 15-marker multiplexed imaging in 3098 human carcinomas reveals 6 major PD-L1-driven immune phenotypes with distinct spatial orchestration

   1. Bady, Elena
   2. Moeller, Katharina
   3. Mandelkow, Tim
   4. Raedler, Jonas B
   5. Yang, Cheng
   6. Ebner, Julia
   7. Lurati, Magalie C J

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Semi-automated validation and quantification of CTLA-4 in 90 different tumor entities using multiple antibodies and artificial intelligence

   1. Dum, David
   2. Henke, Tjark L C
   3. Mandelkow, Tim
   4. Yang, Cheng
   5. Bady, Elena
   6. Raedler, Jonas B
   7. Simon, Ronald

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Villin expression in human tumors: a tissue microarray study on 14,398 tumors

   1. Dum, David
   2. Lennartz, Maximilian
   3. Menz, Anne
   4. Kluth, Martina
   5. Hube-Magg, Claudia
   6. Weidemann, Sören
   7. Fraune, Christoph

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers

   1. Blessin, Niclas C
   2. Li, Wenchao
   3. Mandelkow, Tim
   4. Jansen, Hannah L
   5. Yang, Cheng
   6. Raedler, Jonas B
   7. Simon, Ronald

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
5. Upregulation of PTTG1 is associated with poor prognosis in prostate cancer

   1. Fraune, Christoph
   2. Yehorov, Serhiy
   3. Luebke, Andreas M
   4. Steurer, Stefan
   5. Hube-Magg, Claudia
   6. Büscheck, Franziska
   7. Höflmayer, Doris

   2020 - Forschungsinformationssystem des UKE
6. Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer

   1. Marx, Andreas
   2. Luebke, Andreas M
   3. Clauditz, Till S
   4. Steurer, Stefan
   5. Fraune, Christoph
   6. Hube-Magg, Claudia
   7. Büscheck, Franziska

   2020 - Forschungsinformationssystem des UKE
7. Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion

   1. Fraune, Christoph
   2. Harms, Luisa
   3. Büscheck, Franziska
   4. Höflmayer, Doris
   5. Tsourlakis, Maria Christina
   6. Clauditz, Till S
   7. Simon, Ronald

   2020 - Forschungsinformationssystem des UKE
8. MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass

   1. Fraune, Christoph
   2. Simon, Ronald
   3. Hube-Magg, Claudia
   4. Makrypidi-Fraune, Georgia
   5. Kähler, Christian
   6. Kluth, Martina
   7. Höflmayer, Doris

   2020 - Forschungsinformationssystem des UKE
9. Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers

   1. Luebke, Andreas M
   2. Attarchi-Tehrani, Ali
   3. Meiners, Jan
   4. Hube-Magg, Claudia
   5. Lang, Dagmar S
   6. Kluth, Martina
   7. Tsourlakis, Maria Christina

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
10. Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy

    1. Minner, Sarah
    2. Hager, Dominik
    3. Steurer, Stefan
    4. Höflmayer, Doris
    5. Tsourlakis, Maria Christina
    6. Möller-Koop, Christina
    7. Clauditz, Till S

    2019 - Forschungsinformationssystem des UKE - frei zugänglich
11. SNW1 is a prognostic biomarker in prostate cancer

    1. Höflmayer, Doris
    2. Willich, Carla
    3. Hube-Magg, Claudia
    4. Simon, Ronald
    5. Lang, Dagmar
    6. Neubauer, Emily
    7. Jacobsen, Frank

    2019 - Forschungsinformationssystem des UKE - frei zugänglich
12. The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer

    1. Büscheck, Franziska
    2. Zub, Maciej
    3. Heumann, Asmus
    4. Hube-Magg, Claudia
    5. Simon, Ronald
    6. Lang, Dagmar S
    7. Höflmayer, Doris

    2019 - Forschungsinformationssystem des UKE - frei zugänglich
13. Up regulation of Rho-associated coiled-coil containing kinase1 (ROCK1) is associated with genetic instability and poor prognosis in prostate cancer

    1. Steurer, Stefan
    2. Hager, Benjamin
    3. Büscheck, Franziska
    4. Höflmayer, Doris
    5. Tsourlakis, Maria Christina
    6. Minner, Sarah
    7. Clauditz, Till S

    2019 - Forschungsinformationssystem des UKE
14. High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer

    1. Weidemann, Sören A
    2. Sauer, Charlotte
    3. Luebke, Andreas M
    4. Möller-Koop, Christina
    5. Steurer, Stefan
    6. Hube-Magg, Claudia
    7. Büscheck, Franziska

    2019 - Forschungsinformationssystem des UKE - frei zugänglich
15. Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion

    1. Steurer, Stefan
    2. Schwemmer, Lara
    3. Hube-Magg, Claudia
    4. Büscheck, Franziska
    5. Höflmayer, Doris
    6. Tsourlakis, Maria Christina
    7. Clauditz, Till S

    2019 - Forschungsinformationssystem des UKE
16. Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy

    1. Schroeder, Cornelia
    2. Navid-Hill, Elham
    3. Meiners, Jan
    4. Hube-Magg, Claudia
    5. Kluth, Martina
    6. Makrypidi-Fraune, Georgia
    7. Simon, Ronald

    2019 - Forschungsinformationssystem des UKE
17. Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer

    1. Jacobsen, Frank
    2. Kraft, Juliane
    3. Schroeder, Cornelia
    4. Hube-Magg, Claudia
    5. Kluth, Martina
    6. Lang, Dagmar S
    7. Simon, Ronald

    2017 - Forschungsinformationssystem des UKE - frei zugänglich